Found: 10
Select item for more details and to access through your institution.
TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expression.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 1, p. 1, doi. 10.1002/cti2.1371
- By:
- Publication type:
- Article
Cryptosporidiosis in a transplant recipient with severe intractable diarrhea: Detection of <italic>Cryptosporidium</italic> oocysts by intestinal biopsies.
- Published in:
- Transplant Infectious Disease, 2018, v. 20, n. 2, p. 1, doi. 10.1111/tid.12826
- By:
- Publication type:
- Article
P-023: Assessment of liver stiffness with shear wave elastography for hepatic AL amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S52, doi. 10.1016/S2152-2650(21)02157-1
- By:
- Publication type:
- Article
Therapeutic efficacy of the resorcylic acid lactone LL‐Z1640‐2 for adult T‐cell leukaemia/lymphoma.
- Published in:
- EJHaem, 2023, v. 4, n. 3, p. 667, doi. 10.1002/jha2.758
- By:
- Publication type:
- Article
The importance of retaining physical functions to prevent skeletal‐related events in multiple myeloma patients with bone disease.
- Published in:
- EJHaem, 2022, v. 3, n. 2, p. 480, doi. 10.1002/jha2.402
- By:
- Publication type:
- Article
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 6, p. 626, doi. 10.1007/s12185-024-03763-7
- By:
- Publication type:
- Article
Acute suppression of translation by hyperthermia enhances anti-myeloma activity of carfilzomib.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 3, p. 291, doi. 10.1007/s12185-023-03706-8
- By:
- Publication type:
- Article
Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 3, p. 303, doi. 10.1007/s12185-023-03705-9
- By:
- Publication type:
- Article
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 1, p. 88, doi. 10.1007/s12185-023-03601-2
- By:
- Publication type:
- Article
The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2.
- Published in:
- Antioxidants, 2023, v. 12, n. 1, p. 133, doi. 10.3390/antiox12010133
- By:
- Publication type:
- Article